You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CECLOR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ceclor patents expire, and what generic alternatives are available?

Ceclor is a drug marketed by Lilly and is included in three NDAs.

The generic ingredient in CECLOR is cefaclor. There are thirteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefaclor profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ceclor

A generic version of CECLOR was approved as cefaclor by TEVA on September 4th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CECLOR?
  • What are the global sales for CECLOR?
  • What is Average Wholesale Price for CECLOR?
Summary for CECLOR
US Patents:0
Applicants:1
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 78
Patent Applications: 5,290
DailyMed Link:CECLOR at DailyMed
Drug patent expirations by year for CECLOR

US Patents and Regulatory Information for CECLOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly CECLOR cefaclor CAPSULE;ORAL 050521-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly CECLOR cefaclor FOR SUSPENSION;ORAL 050522-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly CECLOR cefaclor CAPSULE;ORAL 050521-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly CECLOR cefaclor FOR SUSPENSION;ORAL 050522-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly CECLOR CD cefaclor TABLET, EXTENDED RELEASE;ORAL 050673-002 Jun 28, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly CECLOR CD cefaclor TABLET, EXTENDED RELEASE;ORAL 050673-001 Jun 28, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.